Skip to content

Vitamin B12 Unresponsive Methylmalonic Acidemia Type Mut C0342719

Published: July 22, 2026Updated: August 20, 2026

A genetic metabolic disorder that does not respond to vitamin B12 therapy. The body cannot break down certain amino acids, causing harmful substance buildup. Treatment involves strict dietary protein restriction and may include liver transplantation.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Severe metabolic acidosis

!

Neonatal encephalopathy

!

Optic atrophy

Fatigue or weight changes

(metabolic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Hypertrophic cardiomyopathy

(cardiovascular)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Drug therapy with clinical monitoring

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Propionic amino acid-restricted diet

Dietary management involving restriction of propiogenic amino acids including isoleucine, valine, methionine, and threonine to reduce toxic metabolite accumulation. Special metabolic formulas are often required to ensure adequate nutrition while minimizing harmful substrates.

dietary
3

L-carnitine supplementation

Carnitine supplementation to support mitochondrial function and help eliminate toxic acylcarnitine derivatives that accumulate in methylmalonic acidemia. Dosing varies based on individual patient needs and laboratory monitoring.

medication

Additional treatment options

Liver transplantation

Surgical liver transplantation may be considered in severe, refractory cases where metabolic dysfunction cannot be controlled through dietary and medical management alone. Transplantation provides functional enzyme replacement.

surgical

Metabolic parameter monitoring

Regular laboratory monitoring of methylmalonic acid levels, ammonia, electrolytes, and complete blood counts to assess disease control and detect metabolic decompensation early.

monitoring

Specialized metabolic formula

Use of amino acid-modified metabolic formulas specifically designed for methylmalonic acidemia that provide essential nutrients while excluding problematic amino acids.

dietary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Vitamin B12 Unresponsive Methylmalonic Acidemia Type Mut C0342719?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Häberle J, Burlina A, Chakrapani A, et al. Suggested guidelines for the diagnosis and management of methylmalonic and propionic acidemia. Orphanet J Rare Dis. 2022.

guideline2022View source →
2

Fornari A, Sottini L, Zazzeroni F, et al. Metabolic complications in methylmalonic acidemia: pathophysiology and therapeutic approaches. Mol Genet Metab. 2021.

review2021View source →
3

Nizon M, Ottolenghi C, Valayannopoulos V, et al. Long-term outcome of 17 patients with mut0 methylmalonic acidemia after liver transplantation. JIMD Rep. 2020.

clinical_trial2020View source →
4

Manoli I, Myles L, Sloan JL, et al. Targeting the path from genotype to phenotype: advances in treatment of methylmalonic and propionic acidemia. Curr Opin Pediatr. 2023.

review2023View source →

Medication Comparisons

Compare medications used to treat Vitamin B12 Unresponsive Methylmalonic Acidemia Type Mut C0342719. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy